Delivery Order SPE2DB20D3103-SPE2DB24FP8B6

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.08 firm fixed-price contract is for the delivery of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 65 mg/ml vials of the drug Phenobarbital. The $1,008.66 fixed-price contract has a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support...
This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,561.94 firm-fixed-price delivery order is for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Phenobarbital 65 mg/ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,681.70 and a period of performance through May 22, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract has a firm fixed price of $5,283.68 and a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Phenobarbital 65 mg/ml vials, a medication used for various medical conditions. The contract has a ceiling value of $9,704.85 and is a Firm Fixed Price Delivery Order with a final completion date of July 1, 2025. The contract is not set aside and was awarded on June 30, 2025....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 130 mg/ml vials of the pharmaceutical product Phenobarbital. The $3,172.24 contract has a performance period through February 12, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,178.00, is for the delivery of PHENOBARBITAL 65 MG/ML VIAL medical supplies. It is a firm fixed price contract issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract is not designated as a set-aside and is therefore open to full and open competition. Amerisourcebergen...
This federal contract award is for the delivery of 4567707990 - PHENOBARBITAL 130 MG/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 27, 2025 with a ceiling value of $2,190.18. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 28, 2025. This award is not designated as...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP8B6
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,924.30, is for the delivery of PHENOBARBITAL 65 MG/ML VIALML. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of August 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 1:28 PM